Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome. (2020)
Attributed to:
Mesenchymal stem cell-derived extracellular vesicles as a cell-free therapy for ARDS.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/16000617.0114-2020
PubMed Identifier: 32620587
Publication URI: http://europepmc.org/abstract/MED/32620587
Type: Journal Article/Review
Volume: 29
Parent Publication: European respiratory review : an official journal of the European Respiratory Society
Issue: 156
ISSN: 0905-9180